Resumo
Prospective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirin
Fecha
2006-01-01Registro en:
Journal of Hepatology. Amsterdam: Elsevier B.V., v. 44, p. S209-S209, 2006.
0168-8278
10.1016/S0168-8278(06)80562-3
WOS:000237328100562
Autor
Hosp Santa Casa
Hosp Emilio Ribas
Hosp Conceicao
Universidade Estadual Paulista (Unesp)
PUCAMP
Universidade Federal da Bahia (UFBA)
Universidade Federal de São Paulo (UNIFESP)
Hosp Nossa Sra Das Gracas
Universidade Federal de Pernambuco (UFPE)